HSD3B1 Genotype Tied to Prostate-Cancer Outcomes HSD3B1 Genotype Tied to Prostate-Cancer Outcomes

The adrenal-permissive HSD3B1 genotype is associated with worse clinical outcomes in men with metastatic castration-sensitive prostate cancer, according to an analysis of data from a clinical trial.Reuters Health Information

Source: Medscape Pathology Headlines - February 27, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news